The Metro North Health Clinician Research Fellows that commenced in 2021
The 2021 Fellows (L-R): Lata Vadlamudi, Victoria Eley, Natasha Roberts, Dylan Flaws, Thuy Frakking
Professor Victoria Eley
Senior Staff Specialist, Anaesthesia, The Royal Brisbane and Women’s Hospital
Demonstrating the effect of pre-delivery antibiotics on the neonatal intestinal microbiome and immune system
Victoria’s Fellowship looked at optimising clinical outcomes for mother and child following a caesarean section by determining if pre-incisional antibiotics administered to the mother at caesarean section increases childhood allergic disease.
Dr Natasha Roberts
Specialist Nurse and Conjoint Clinical Research Fellow, STARS
Addressing unmet needs in prostate cancer care
Natasha led a body of research seeking to identify and address unmet needs in prostate cancer care by developing a collaborative, clinically driven program of research that improves support and outcomes for men living with prostate cancer.
Professor Dylan Flaws
Psychiatrist, Metro North Mental Health
Greater Recovery After Critical illnEss (GRACE)
Dylan’s research seeks to develop an improved conceptual model of Post Intensive Care Syndrome, developed clinical decision aids and developed new ways of optimising critical illness recovery.
Dr Thuy Frakking
Research Director, Caboolture Hospital | Advanced Speech Pathologist (Paediatrics)
Standardisation of swallowing sounds to provide better access to safer, more accurate and improved reliability for the detection of swallowing disorders in neonates and children
Thuy’s Fellowship aimed to establish novel swallowing sounds in pre-term neonates to progress towards use of automated cervical auscultation to accurately detect swallowing impairment; and standardise cervical auscultation training for Speech Pathologists to accurately detect swallowing impairment.
Associate Professor Lata Vadlamudi
Senior Staff Specialist, Neurology, The Royal Brisbane and Women’s Hospital
Developing a Queensland neuro-genomics service to underpin the era of precision-based medicine
Lata’s program of research applied genomics to improve diagnoses and personalise treatment for patients, in developing a patient-specific, in vitro drug screening platform for drug-resistant epilepsy patients.